Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)

Phase 2

Completed

Conditions: COVID-19

Interventions: Drug: Placebo
Drug: Duvelisib

First Posted Date: 2020-07-27

Last Posted Date: 2023-04-07

Lead Sponsor: Emory University

Target Recruit Count: 47

Registration Number: NCT04487886

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Personalized Autologous Transplant for Multiple Myeloma

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation
Drug: Melphalan
Other: Questionnaire Administration

First Posted Date: 2020-07-23

Last Posted Date: 2025-05-31

Lead Sponsor: Emory University

Target Recruit Count: 90

Registration Number: NCT04483206

Locations: 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸
University Illinois Chicago, Chicago, Illinois, United States

Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)

Not Applicable

Completed

Conditions: Type 2 Diabetes
End-Stage Renal Disease

Interventions: Device: Dexcom real-time G6 Continuous Glucose Monitoring System (CGM)
Diagnostic Test: POC BG

First Posted Date: 2020-07-16

Last Posted Date: 2025-02-10

Lead Sponsor: Emory University

Target Recruit Count: 53

Registration Number: NCT04473430

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States
🇺🇸
Grady Health System (non-CRN), Atlanta, Georgia, United States

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Phase 2

Recruiting

Conditions: Solid Tumor

Interventions: Drug: Sirolimus
Drug: Cyclophosphamide
Drug: Etoposide
Drug: Celecoxib

First Posted Date: 2020-07-14

Last Posted Date: 2024-11-13

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT04469530

Locations: 🇺🇸
Aflac Cancer & Blood Disorders Centers, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

and more 2 locations

Convalescent Plasma in Pediatric COVID-19

Early Phase 1

Completed

Conditions: COVID

Interventions: Biological: Convalescent Plasma (CP)
Drug: Standard COVID-19 therapies

First Posted Date: 2020-07-07

Last Posted Date: 2021-11-22

Lead Sponsor: Emory University

Target Recruit Count: 3

Registration Number: NCT04458363

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity

Phase 4

Completed

Conditions: COVID-19

Interventions: Biological: Therapeutic plasma exchange (TPE)
Other: Standard of care

First Posted Date: 2020-06-22

Last Posted Date: 2022-12-21

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT04441996

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

HIV-Prevention Smartphone Game Trial

Not Applicable

Active, not recruiting

Conditions: HIV

Interventions: Behavioral: Tumaini Mobile Phone Game
Behavioral: Control Mobile Phone Game

First Posted Date: 2020-06-18

Last Posted Date: 2025-06-05

Lead Sponsor: Emory University

Target Recruit Count: 1000

Registration Number: NCT04437667

Locations: 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya

Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19

Phase 3

Active, not recruiting

Conditions: Pneumonia
Severe Acute Respiratory Syndrome
Symptomatic COVID-19 Infection Laboratory-Confirmed

Interventions: Radiation: Low Dose Radiation Therapy
Other: Best Practice

First Posted Date: 2020-06-16

Last Posted Date: 2023-08-14

Lead Sponsor: Emory University

Target Recruit Count: 14

Registration Number: NCT04433949

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad

Not Applicable

Completed

Conditions: Dementia
Cognitive Impairment

Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBTi) via Videoconference

First Posted Date: 2020-06-11

Last Posted Date: 2023-03-20

Lead Sponsor: Emory University

Target Recruit Count: 44

Registration Number: NCT04426838

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Goizueta Alzheimer's Disease Research Center, Atlanta, Georgia, United States

Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

Phase 1

Recruiting

Conditions: Metastatic Skin Squamous Cell Carcinoma
Recurrent Skin Squamous Cell Carcinoma

Interventions: Biological: Cemiplimab
Radiation: Radiation Therapy
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2020-06-11

Last Posted Date: 2024-08-06

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT04428671

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy